PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Benzathine Benzylpenicillin→

Benzathine Benzylpenicillin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
1538-09-6
Molecular formula
C48H56N6O8S2
Molecular weight
909.1 g/mol
Drug class
Natural penicillin (penicillin G)beta-lactam antibacterial
Mechanism of action
Binds penicillin-binding proteins and inhibits transpeptidation during bacterial peptidoglycan synthesis, weakening the cell wall and producing bactericidal activity in susceptible organisms.
Indications / reported uses
  • Treatment of infections caused by benzylpenicillin-susceptible bacteria, including selected streptococcal, pneumococcal, meningococcal, clostridial and spirochaetal infections; the exact indication, route and regimen depend on the clinical setting and formulation

Sources: UK SmPC — Benzylpenicillin sodium · NHS — Benzylpenicillin · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Benzathine Benzylpenicillin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Benzathine Benzylpenicillin Permitted Daily Exposure (PDE) report (the Benzathine Benzylpenicillin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Benzathine Benzylpenicillin Occupational Exposure Limit (OEL) report (the Benzathine Benzylpenicillin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.